These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1140928)

  • 1. Glomerulonephritis--1974.
    Cameron JS
    Ir J Med Sci; 1975 Jun; SUPPL():72-80. PubMed ID: 1140928
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment and diagnosis of glomerulonephritis and nephrotic syndrome].
    Nagasawa T
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):409-13. PubMed ID: 2332698
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and prognostic significance of histological classification in glomerulonephritis].
    Renner E; Edel H; Eigler J; Buchborn E
    Klin Wochenschr; 1969 Jul; 47(14):752-9. PubMed ID: 5382556
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic problems of glomerulonephritis].
    Dutz H; Philipp H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):554-60. PubMed ID: 5570284
    [No Abstract]   [Full Text] [Related]  

  • 5. Glomerulonephritis--1974.
    Cameron JS
    Ir Med J; 1975 Jun; Suppl():73-80. PubMed ID: 241733
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotic syndrome due to immunoglobulin M mesangial glomerulonephritis preceding juvenile idiopathic arthritis.
    Voyer LE; Alvarado C; Cuttica RJ; Balestracci A; Zardini M; Lago N
    Iran J Kidney Dis; 2013 May; 7(3):231-4. PubMed ID: 23689157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
    Jabur WL; Saeed HM
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus.
    Fayaz A; Pirson Y; Cosyns JP; Yango J; Lambert M
    Clin Nephrol; 2008 Apr; 69(4):290-3. PubMed ID: 18397704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of associated immunosuppressive -- antiphlogistic treatment of proliferative glomerulonephritis (author's transl)].
    Szewczyk Z; Szepietowski T; Falkiewicz K; Rabczyński J
    Przegl Lek; 1976; 33(5):550-4. PubMed ID: 948642
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS; Makurov AI
    Ter Arkh; 1992; 64(8):47-50. PubMed ID: 1440396
    [No Abstract]   [Full Text] [Related]  

  • 11. The differential approach in the treatment of chronic glomerulonephritis.
    Tschoukanov C; Tishkov I
    Int Urol Nephrol; 1982; 14(1):95-100. PubMed ID: 7118492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of primary chronic glomerulonephritis].
    Risler T; Braun N; Erley CM
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrotic syndrome revealing malignant thymoma].
    Schillinger F; Milcent T; Wolf C; Gulino R; Montagnac R
    Presse Med; 1998 Jan; 27(2):60-3. PubMed ID: 9768051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of glomerulonephritis].
    Risler T; Braun N; Erley CM
    Internist (Berl); 2003 Sep; 44(9):1083-9. PubMed ID: 14566461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
    Nazar PS
    Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-inflammatory activity of glucocorticoids in nephrology].
    Nykula TD; Bondur VV; Moĭseienko VO; Aleksieieva NH
    Lik Sprava; 2013; (5):94-8. PubMed ID: 24605641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrotic syndrome due to primary renal disease. Study of therapeutic response (author's transl)].
    Casado S; Ruilope LM; Oliva H; Hernando L
    An Esp Pediatr; 1974; 7(2):124-30. PubMed ID: 4849232
    [No Abstract]   [Full Text] [Related]  

  • 18. [QImmunosuppressive therapy of glomerulonephritis].
    Asamer H; Dittrich M
    Med Klin; 1970 May; 65(22):1076-81. PubMed ID: 5521134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ; Wetzels JF
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2832-8. PubMed ID: 10065257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunopathological bases of the treatment of glomerulonephritis].
    Vercellone A; Segoloni G; Stratta P; Coppo R; Triolo G; Messina M
    Minerva Med; 1978 Aug; 69(38):2611-24. PubMed ID: 152419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.